{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:20:14Z","timestamp":1779301214520,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cancergen.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T05:45:33Z","timestamp":1497073533000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"216-217","author":[{"given":"Chang Ahn","family":"Seol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Uk","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongsoo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Jeoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoo Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eul-Ju","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2017.06.001_bib0010","first-page":"3135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique","volume":"87","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood-2009-07-232124","article-title":"A population-based cytogenetic study of adults with acute lymphoblastic leukemia","volume":"115","author":"Moorman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0020","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0025","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study","volume":"111","author":"Pullarkat","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0030","first-page":"957","article-title":"Incidence and clinical outcome of children with BCR\/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92","volume":"10","author":"Schlieben","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909093730","article-title":"Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy","volume":"33","author":"Uckun","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0040","first-page":"20","article-title":"Cytogenetics of chronic myelogenous leukemia","volume":"25","author":"Bernstein","year":"1988","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0950-3536(87)80034-3","article-title":"Chromosome abnormalities in CML","volume":"1","author":"Hagemeijer","year":"1987","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0050","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.bbmt.2015.03.021","article-title":"Impact of additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"21","author":"Aldoss","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.10227","article-title":"Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome\/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan","volume":"71","author":"Ko","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1365-2141.1996.d01-1968.x","article-title":"Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia","volume":"95","author":"Rieder","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04736.x","article-title":"Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B","volume":"124","author":"Wetzler","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0070","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00277-006-0099-z","article-title":"Outcome of treatment in adults with Philadelphia chromosome-positive and\/or BCR-ABL\u2014positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG)","volume":"85","author":"Wrzesien-Kus","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00277-009-0720-z","article-title":"Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy","volume":"88","author":"Li","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.leu.2403714","article-title":"Genetic heterogeneity of BCR\/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics","volume":"19","author":"Primo","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0085","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0090","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.6004\/jnccn.2015.0153","article-title":"Acute lymphoblastic leukemia, version 2.2015","volume":"13","author":"Alvarnas","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0095","series-title":"ISCN 2013: An International System for Human Cytogenetic Nomenclature (2013)","author":"Shaffer","year":"2013"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V76.3.489.489","article-title":"Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study","volume":"76","author":"Crist","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01715353","article-title":"Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia","volume":"64","author":"Gotz","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11899-013-0155-4","article-title":"Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"8","author":"Fielding","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0115","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.hoc.2009.07.007","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"23","author":"Ravandi","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.leu.2403324","article-title":"Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome","volume":"18","author":"Heerema","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0125","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1200\/JCO.2014.55.5763","article-title":"Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4","volume":"32","author":"Angiolillo","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0130","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/pbc.24149","article-title":"Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group","volume":"59","author":"Termuhlen","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0135","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.bmt.1703913","article-title":"High-hyperdiploidy in Philadelphia positive adult acute lymphoblastic leukaemia: case-series and review of literature","volume":"31","author":"Tauro","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergen.2017.06.001_bib0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajh.24625","article-title":"Poor outcomes associated with +der(22)t(9;22) and -9\/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor","volume":"92","author":"Short","year":"2017","journal-title":"Am J Hematol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217300807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217300807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:20Z","timestamp":1761896600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217300807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":27,"alternative-id":["S2210776217300807"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.06.001","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}